Barclays’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2 | Sell |
|
|||||
|
2025
Q2 | $24K | Sell |
|
|||||
|
2025
Q1 | $89K | Sell |
|
|||||
|
2024
Q4 | $118K | Buy |
|
|||||
|
2024
Q3 | $192K | Buy |
|
|||||
|
2024
Q2 | $51K | Sell |
|
|||||
|
2024
Q1 | $139K | Sell |
|
|||||
|
2023
Q4 | $200K | Buy |
|
|||||
|
2023
Q3 | $28K | Sell |
|
|||||
|
2023
Q2 | $36K | Buy |
|
|||||
|
2023
Q1 | $21K | Sell |
|
|||||
|
2022
Q4 | $33K | Buy |
|
|||||
|
2022
Q3 | $9K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $31K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $79K | Buy |
|
|||||
|
2019
Q1 | $42K | Buy |
|
|||||
|
2018
Q4 | $1K | Sell |
|
|||||
|
2018
Q3 | $93K | Buy |
|
|||||
|
2018
Q2 | $25K | Sell |
|
|||||
|
2018
Q1 | $199K | Buy |
|
|||||
|
2017
Q4 | $150K | Buy |
|
|||||
|
2017
Q3 | $8K | Buy |
|
|||||
|
2017
Q2 | $3K | Sell |
|
|||||
|
2017
Q1 | $7K | Buy |
|
|||||
|
2016
Q4 | $6K | Sell |
|
|||||
|
2016
Q3 | $11K | Buy |
|
|||||
|
2016
Q2 | $2K | Hold |
|
|||||
|
2016
Q1 | $2K | Sell |
|
|||||
|
2015
Q4 | $21K | Buy |
|
|||||
|
2015
Q3 | $7K | Sell |
|
|||||
|
2015
Q2 | $73K | Sell |
|
|||||
|
2015
Q1 | $197K | Buy |
|
|||||
|
2014
Q4 | $16K | Sell |
|
|||||
|
2014
Q3 | $17K | Sell |
|
|||||
|
2014
Q2 | $42K | Buy |
|
|||||
|
2014
Q1 | $29K | Buy |
|
|||||
|
2013
Q4 | $29K | Sell |
|
|||||
|
2013
Q3 | $32K | Buy |
|
|||||
|
2013
Q2 | $36K | Buy |
|